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Abstract
Welcome to CytoJournal! We would like to introduce you to your journal, one that is run by and
for the scientific cytopathology community with incontestable benefits of Open Access, and
support from Cytopathology Foundation, Inc. http://www.cytopathology-foundation.org/
index.htmlCytoJournal is a peer-reviewed, PubMed indexed, online journal, publishing research in
the field of cytopathology and related areas, with world wide free access. Authors submitting to
CytoJournal retain the copyright to their hard earned work.
Welcome to CytoJournal http://www.cytojournal.com/!
We would like to introduce you to your journal, one that
is run by and for the scientific cytopathology community
with incontestable benefits of Open Access http://
www.biomedcentral.com/openaccess/.  CytoJournal  is a
peer-reviewed cytopathology journal is owned and sup-
ported by Cytopathology Fondation, Inc. http://
www.cytopathology-foundation.org/index.html It is a
PubMed indexed, online journal, publishing research in
the field of cytopathology and related areas with world
wide free access. Authors submitting to CytoJournal retain
the copyright to their hard earned work.
Why CytoJournal is needed
One could argue whether we need more journals in
cytopathology, but without a shadow of doubt there is a
global need for greater access to scientific information in
this field. As an Open Access journal CytoJournal will
meet this need, by removing subscription barriers.
Communication in general has been revolutionized in the
last decade. With the emergence of the internet, entire
libraries of scientific information are potentially just a
mouse click away. Open Access to quality controlled, sci-
entific information to the general public and scientific
community alike is extremely valuable for harvesting the
fruits of hard work by academicians.
However, to date little has been done to realize the poten-
tial of this technological revolution. It is now affordable
to make our hard earned scientific information available
to a much wider audience. Millions of students, teachers,
physicians, scientists, general public, and other potential
readers can have free access to the gold mine of this scien-
tific information.
The traditional model for journal publication has per-
formed an admirable job of disseminating research and
advancing science. Unfortunately, it neither can fully uti-
lize recent technology nor extend its benefits to the scien-
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tific community and the general public. Principally, why
should scientific information generated by academicians
and published without charge, not be freely available?
Giving away the copyrights to the original research reports
and then paying for access of the same material is para-
doxically anachronistic.
With the advent of the internet and image digitization, the
time has come for the development and implementation
of a new model – a model beneficial to the scientific com-
munity and general public, alike. The recent adoption of
an Open Access model by the Public Library of Science
(PLoS) [1] and its recognition by other scientific organiza-
tions, including the National Institute of Health (NIH),
has generated significant community interest. This has
provided impetus for the creation of new journals such as
CytoJournal with increasing support to open access philos-
ophy by some of the existing leading journals.
The benefits of an online journal can include rapid turna-
round time, real time publication, significant cost savings,
and a reduction in the environmental burden engendered
in the production and disposal of a print publication. Pre-
sumably in the future, the majority of research publica-
tions will be of this type [2].
Free flow of scientific information is crucial for advance-
ments in diagnosis and management of diseases in both
the developed and developing world. Simply providing a
conduit of information is not enough. There is one matter
involving the human element that must be dealt with –
peer review. We do not see a future where authors post
their manuscripts on the web without peer-review. Sci-
ence requires that publications be properly vetted (peer-
reviewed) and experimental findings logically presented.
In brief, standards must be maintained! This critical role
is played by peer review. Acting on behalf of the scientific
community, it is peer review that helps the scientific com-
munity distinguish between legitimate scientific work and
quackery [3-7]. Thus, to maintain the quality and confi-
dence, peer review will continue to be the keystone of sci-
entific publishing.
The peer-review process at CytoJournal combines the
expertise of both professional editors, who are available to
survey the broad landscape of cytopathology, and aca-
demic editors, who understand deeply the strengths and
limitations of their specific area of research. Every article
that is published in CytoJournal will be reviewed carefully
by selected reviewers, in addition to evaluation by a man-
aging/academic editor and professional editor, who work
together throughout the editorial process. A summary of
your peer review process is illustrated in Figure 1.
Definition of Open Access
CytoJournal's Open Access policy changes the way in which
articles are published. First, all articles become freely and
universally accessible online, and so an author's work can
be read by anyone, free of charge. Second, the authors
hold copyright for their work and grant anyone the right
to reproduce and disseminate the article, provided that it
is correctly cited and no errors are introduced [8]. Third, a
copy of the full text of each Open Access article is perma-
nently archived in an online repository separate from the
journal. CytoJournal's articles are archived in PubMed Cen-
tral [9], the US National Library of Medicine's full-text
repository of life science literature, and also in repositories
at the University of Potsdam [10] in Germany, at INIST
[11] in France and in e-Depot, the National Library of the
Netherlands' digital archive of all electronic publications
[12].
Benefits of Open Access
Open Access has four broad benefits for science and the
general public. First, authors are assured that their work is
disseminated to the widest possible audience, given that
there are no barriers to their work. This is accentuated by
the authors being free to reproduce and distribute their
work, for example by placing it on their institution's web-
site. It has been suggested that free online articles are more
highly cited because of their easier availability [13]. Sec-
ond, the information available to researchers will not be
limited by their library's budget, and the widespread avail-
ability of articles will enhance literature searching [14].
Third, the results of publicly funded research will be acces-
sible to all taxpayers and not just those with access to a
library with a subscription. As such, Open Access could
help to increase public interest in, and support of,
research. Note that this public accessibility may become a
legal requirement in the USA if the proposed Public
Access to Science Act is made law [15]. Fourth, a country's
economy will not influence its scientists' ability to access
articles because resource-poor countries (and institutions)
will be able to read the same material as wealthier ones
(although creating access to the internet is another mat-
ter) [16].
Open Access Publishing Model and Finance
Open Access facilitates the transformation of scientific lit-
erature from rows of printed journals on library shelves to
an instantly searchable archive of data. Liberating scien-
tific literature from the vestiges of paper publication intro-
duces the potential of various opportunities such as
navigating, integrating, mining, annotating, and mapping
connections in the high-dimensional space of scientific
knowledge.
To provide Open Access, CytoJournal will use a new busi-
ness model. Our editorial expenses (managing peerCytoJournal 2004, 1:1 http://www.cytojournal.com/content/1/1/1
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review, providing editorial insight, and ensuring the high-
est production standards) will be supported by corporate
sponsors through Cytopathology Foundation, Inc. http://
www.cytopathology-foundation.org/index.html and hon-
orary pro bono services by the academicians (Figure 2). The
publication cost for our publishers, BioMed Central, will
be recovered by imposing a modest charge (currently US$
525) to authors for each article accepted for publication
after peer review. There is no charge for the submission of
a manuscript and therefore, if the manuscript is submitted
but not accepted for publication, the authors will not be
charged.
CytoJournal's online peer review process Figure 1
CytoJournal's online peer review process.
Online submission 
of the manuscript to 
the editorial office
Abstract  directed to the 
executive editor by 
Managing editor with 
academic support / 
participation by trainee 
and faculty colleagues
Monitoring/Academic 
editor is identified by the 
Executive editor 
(Managing editor will 
follow the progress)
Abstract sent to 
Monitoring/Academic
Editor
At least 2 ad hoc reviewers are
identified and communicated to 
Managing editor
Manuscript is forwarded to the 
ad hoc reviewers after they 
have accepted the invitation to 
review, based on initial abstract 
sent with the invitation 
The comments by the 
reviewers sent to Editorial 
office are forwarded by 
Managing editor to be 





taken by both or one of the 
Editors-in-chief ** , based on 
the reviewers comments and 
monitoring editor’s comments.
If revision is indicated the manuscript is 
re-evaluated based on reviewer’s and / 
or Monitoring/Academic editor’s
comments and final decision as to 
Accept/Decline by both or one of the 
Editors-in-chief ** is communicated to 
the author by Managing editor.
*Maximum two revisions will be allowed. 
**With reference to some specific situations additional members of the editorial 
board will be consulted by both or either of the editors-in-chief.CytoJournal 2004, 1:1 http://www.cytojournal.com/content/1/1/1
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Our sponsors do not influence in any way the content of
CytoJournal and it's editorial and publication decisions.
However, they will be acknowledged and their links will
be displayed on the home page of CytoJournal as a thank
you note.
Fee Waivers
We understand that there are many scientists who might
wish to publish in our journal but do not have access to
grant funds or institutional support. For such authors, a
decision can be made by the Editors-in-Chief to waive
publication fees. Furthermore, the fee will automatically
be waived for authors from institutes that are members of
BioMed Central http://www.biomedcentral.com/inst/.
We never want our publication charges to be a barrier to
publication and are committed to publishing any manu-
script that our editors and reviewers deem to be appropri-
ate for the journal; we will treat the costs of handling these
papers as a fundamental expense of running a high-qual-
ity journal through support from Cytopathology Founda-
tion Inc.
Joining Forces
CytoJournal  is your journal and you can lead the way.
However, we have to face and overcome a few traditional
obstacles. First, an unfamiliarity to the Open Access
model. Second, lack of the benefits of an established
"brand name" aura. Because of this, despite stringent
Core Principles of 'CytoJournal' and 'Cytopathology-Foundation' Figure 2
Core Principles of 'CytoJournal' and 'Cytopathology-Foundation'
S. No Feature Details
1 Open access.  All material submitted to CytoJournal, will be published under an open access 
philosophy [16] that allows unrestricted use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
2 Excellence.  CytoJournal will strive to set the highest standards for excellence in everything we 
do: in content, style, and aesthetics of presentation; in editorial performance at every 
level; in transparency and accessibility to the scientific community and public; and in 
educational value.
3 Scientific integrity.  CytoJournal is committed to a fair, rigorous editorial process. Scientific quality and 
importance will be the sole considerations in publication decisions. The basis for 
decisions will be communicated to authors.
4 Breadth.  CytoJournal focuses on publishing valuable scientific / scholarly articles on high-
impact research in the field of cytopathology.
5 Cooperation.  Cytopathology-Foundation welcomes and will actively seek opportunities to work
cooperatively with any group (scientific/scholarly societies, physicians, patient 
advocacy groups, educational organizations) and any publisher who shares our 
commitment to open access and to making scientific information available for the 
good of science and the public.
6 No financial barrier 
to authors. 
The publisher- BioMed Central will charge authors a fair price that reflects the actual 
cost of publication. However, the ability of authors to pay publication charges will 
never be a consideration in the decision whether to publish. Cytopathology-




Every publishing decision will have at its heart the needs of the constituencies that 
we serve (cytopathologists, cytotechnologists, physicians, educators, scientists, and 
the public).
8 Universalization.  Science is international. Cytopathology-Foundation aims to be a truly international 
organization by providing access to the scientific literature in CytoJournal to anyone, 
anywhere; by publishing works from every nation; and by engaging a geographically 
diverse group of scientists in the editorial process.
9 Public resource.  Cytopathology-Foundation provides support to publish scientific research ideas and 
discoveries in CytoJournal.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
CytoJournal 2004, 1:1 http://www.cytojournal.com/content/1/1/1
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standards and an extraordinary editorial team, CytoJournal
may have an uphill task.
Private foundations with a commitment to science and
education have contributed generously to the cause. Like
any new business, Cytopathology Foundation Inc. needed
to raise funds to cover our startup costs. Initial support
from Cytopathology Foundation Inc. and the publisher,
BioMed Central, has enabled us to launch CytoJournal.
Other individuals and organizations http://www.cytopa
thology-foundation.org/page5.html have also provided
generous and welcome support. The start-up support
made it possible to assemble an outstanding editorial
board and staff, who have accomplished an extraordinary
feat of launching this new premiere journal in cytopathol-
ogy.
We wish to thank and applaud the efforts and spirit of the
pioneering authors who chose to send their articles to
CytoJournal. In the end, it is the contributions by authors
like you that will make CytoJournal a collective success. We
encourage you to participate in the future of CytoJournal
by reading, citing, submitting manuscript, sending any
suggestions, and joining the panel of core reviewers.
Bookmark the home page of Cytojournal http://www.cyto
journal.com for your quick reference! You may also link
CytoJournal web site or recommend its linking through
various other web sites.
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